InstalabLiver Function Panel
Should you take a Liver Function Panel test?
This test is most useful if any of these apply to you.
9 Biomarkers Included
- ALTThe most liver-specific enzyme in the panel, released into blood when liver cells are inflamed or injured by fat, hepatitis, medications, or alcohol.A persistently high ALT is the panel's clearest early sign of ongoing liver cell injury.
- ASTA second injury enzyme found in liver but also muscle, so it adds context and, read next to ALT, hints at the cause.AST running more than twice as high as ALT points toward alcohol-related liver injury.
- ALPAlkaline phosphatase rises when bile flow is blocked, marking cholestasis, though it can also come from bone rather than the liver.ALP high out of proportion to ALT and AST signals a bile-flow rather than a liver-cell problem.
- GGTA bile-duct enzyme that confirms whether a high ALP comes from the liver and flags alcohol or bile-flow problems.A high GGT is the single most consistent liver marker linked to higher long-term mortality risk.
- Total BilirubinThe waste pigment from recycled red blood cells. Rising levels can tint skin yellow and signal the liver is struggling to clear it.High total bilirubin is worth splitting into direct and indirect fractions to find the cause.
- Direct BilirubinThe processed (conjugated) form. When it makes up a large share of the total, the problem usually lies in the liver or bile ducts.A high direct fraction points to bile blockage or liver disease rather than red-cell breakdown.
- Indirect BilirubinThe unprocessed (unconjugated) form. Elevation with normal enzymes is often the harmless genetic trait Gilbert syndrome or faster red-cell turnover.High indirect bilirubin with normal enzymes is usually benign, not a sign of liver damage.
- AlbuminThe main protein the liver builds. Low levels can reflect reduced liver synthetic capacity, though inflammation and poor nutrition also lower it.A falling albumin can signal chronic or advanced liver disease affecting the organ's building capacity.
- Total ProteinMeasures albumin plus antibodies together, giving context for a low albumin and hinting at inflammation or immune activity.Total protein shows whether a low albumin sits within broader protein loss or alongside high antibody levels.
About Liver Function Panel
Your liver runs hundreds of jobs quietly, and it rarely complains until a problem is well advanced. This panel reads that silent organ from several angles in a single blood draw, catching strain long before symptoms appear.
No one number tells the whole story here. The value is the pattern across nine markers, which can separate an inflamed liver from a blocked bile duct from a liver losing its ability to build proteins.
What This Panel Reveals
The panel answers three linked questions at once: are liver cells being injured, is bile flowing normally, and is the liver still doing its manufacturing work. Each group of tests speaks to one of those questions, and reading them side by side is what turns scattered numbers into a diagnosis.
The injury story comes from two enzymes that live inside liver cells and leak into the blood when those cells are damaged: alanine aminotransferase (ALT) and aspartate aminotransferase (AST). ALT is fairly specific to the liver, while AST also comes from muscle, so a hard workout or a muscle injury can raise it without any liver problem.
The bile story comes from two more enzymes: alkaline phosphatase (ALP) and gamma-glutamyl transferase (GGT). When bile cannot flow freely, these climb. ALP alone can also come from bone, so GGT is the tiebreaker that confirms a high ALP is coming from the liver and bile ducts.
The waste story comes from bilirubin, the yellow-orange pigment left over when old red blood cells are recycled. Total bilirubin is split into a processed form (direct, or conjugated) and an unprocessed form (indirect, or unconjugated), and the balance between them points to where a problem sits. Finally, albumin and total protein reflect the liver's building capacity, since albumin is made only by the liver.
How to Read Your Results Together
The pattern matters more than any single high value. Below are the combinations worth recognizing in your own results.
| Pattern | What It Suggests |
|---|---|
| ALT and AST high, ALP near normal | Liver cell injury (fatty liver, viral hepatitis, medication effect, or alcohol) |
| ALP and GGT high, out of proportion to ALT and AST | A bile-flow problem rather than a liver-cell problem |
| AST more than twice ALT | Points toward alcohol-related liver injury, though advanced scarring of any cause can also raise AST above ALT |
| Indirect bilirubin high, all enzymes normal | Usually harmless, such as the common genetic trait Gilbert syndrome or faster red-cell turnover |
A raised direct (conjugated) bilirubin points toward the liver or bile ducts, while a raised indirect (unconjugated) bilirubin with normal enzymes usually is not a sign of liver damage at all. Among the enzymes, GGT carries the strongest long-term signal: in a meta-analysis of general populations, people with the highest GGT had about a 60 percent higher risk of death over follow-up than those with the lowest (relative risk 1.60), and ALP showed a similar but smaller pattern (relative risk 1.38).
What to Do with Your Results
Start by confirming. Values swing from day to day, so a single mildly abnormal result is worth repeating before acting. If a liver-cell (hepatocellular) injury pattern holds, the next steps are usually hepatitis testing, iron studies, and a blood sugar check, since fatty liver tied to metabolism is now the most common driver. A bile-flow (cholestatic) pattern of high ALP and GGT more often leads to imaging of the bile ducts.
This panel does not measure scarring. Normal enzymes do not rule out advanced fibrosis, and routine liver tests perform poorly at detecting it (the best single routine marker in one study reached only modest accuracy, an area under the curve of 0.752). To estimate scarring, these results are folded into a simple score called FIB-4 using a platelet count and your age, then confirmed with an elastography scan if the score is elevated.
For serial tracking, compare each panel against your own baseline rather than the population range. A steady rise across draws is more meaningful than one number crossing a line. If enzymes jump sharply, especially after starting a new medication or supplement, retest within days to weeks rather than waiting months.
When Results Can Be Misleading
Several things move multiple markers at once and have nothing to do with liver disease. Strenuous exercise in the day or two before your draw can raise AST and ALT, mainly by releasing them from muscle rather than the liver. There is even a mild seasonal effect, with AST and ALT running roughly 6 percent higher in winter.
The enzymes also carry real day-to-day biological variation, on the order of 9 percent for ALT and GGT within the same person between draws under controlled conditions, with real-world swings often larger. That is one more reason to weigh trends over single values. Albumin and total protein are less specific still, since inflammation, kidney disease, and poor nutrition can lower them independent of the liver.